chr15-65003100-GCTT-G
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PM4_Supporting
The NM_139242.4(MTFMT):βc.1129_1131delβ(p.Lys377del) variant causes a inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000344 in 1,600,622 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (β β ).
Frequency
Genomes: π 0.000040 ( 0 hom., cov: 31)
Exomes π: 0.000034 ( 0 hom. )
Consequence
MTFMT
NM_139242.4 inframe_deletion
NM_139242.4 inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 1.25
Genes affected
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 3 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PM4
Nonframeshift variant in NON repetitive region in NM_139242.4. Strenght limited to Supporting due to length of the change: 1aa.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MTFMT | NM_139242.4 | c.1129_1131del | p.Lys377del | inframe_deletion | 9/9 | ENST00000220058.9 | |
MTFMT | XM_005254158.6 | c.1282_1284del | p.Lys428del | inframe_deletion | 9/9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MTFMT | ENST00000220058.9 | c.1129_1131del | p.Lys377del | inframe_deletion | 9/9 | 1 | NM_139242.4 | P1 | |
MTFMT | ENST00000558460.5 | c.1129_1131del | p.Lys377del | inframe_deletion, NMD_transcript_variant | 9/10 | 5 | |||
MTFMT | ENST00000560717.5 | c.*599_*601del | 3_prime_UTR_variant, NMD_transcript_variant | 8/8 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000402 AC: 6AN: 149384Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
6
AN:
149384
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000164 AC: 4AN: 243566Hom.: 0 AF XY: 0.0000151 AC XY: 2AN XY: 132266
GnomAD3 exomes
AF:
AC:
4
AN:
243566
Hom.:
AF XY:
AC XY:
2
AN XY:
132266
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000338 AC: 49AN: 1451124Hom.: 0 AF XY: 0.0000319 AC XY: 23AN XY: 721386
GnomAD4 exome
AF:
AC:
49
AN:
1451124
Hom.:
AF XY:
AC XY:
23
AN XY:
721386
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000401 AC: 6AN: 149498Hom.: 0 Cov.: 31 AF XY: 0.0000413 AC XY: 3AN XY: 72708
GnomAD4 genome
AF:
AC:
6
AN:
149498
Hom.:
Cov.:
31
AF XY:
AC XY:
3
AN XY:
72708
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 17, 2023 | This variant, c.1129_1131del, results in the deletion of 1 amino acid(s) of the MTFMT protein (p.Lys377del), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (rs769122836, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with MTFMT-related conditions. ClinVar contains an entry for this variant (Variation ID: 1031156). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Aug 11, 2021 | In-frame deletion of 1 amino acids in a non-repeat region; In silico analysis supports that this variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge - |
Combined oxidative phosphorylation defect type 15 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Baylor Genetics | Apr 05, 2019 | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. - |
Combined oxidative phosphorylation defect type 15;C4748826:Mitochondrial complex 1 deficiency, nuclear type 27 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Sep 01, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at